2011 ASH Program Book - American Society of Hypertension

Saturday Afternoon MAY 21
Posters
PO-106:
PO-107:
PO-108:
PO-109:
PO-110:
PO-111:
Antihypertensive Drug Use in Children: Are the
Drugs Labeled and Indicated
Joseph Flynn†, 1 W. Pete Welch, 2 Wenya Yang, 2 Drew
Braucht, 2 Perdita Taylor‐Zapata, 3 Anne Zajicek. 3
1 Seattle Children’s Hospital, Seattle, WA, US; 2 The
Lewin Group, Inc., Falls Church, VA, US; 3 Eunice
Kennedy Shriver National Institute of Child Health
and Human Development, Bethesda, MD, US.
Clinical and Demographic Characteristics of
Children with Hypertension: New Multicenter Data
Joseph Flynn†, 1 Ying Zhang, 2 Susan Solar‐Yohay, 2
Victor Shi. 2 1 Seattle Children’s Hospital, Seattle, WA,
US; 2 Novartis Pharma AG, East Hanover, NJ, US.
Cardiovascular Risk Factors in Obese Children and
Adolescents
Isabel Torro, 1,2 Julio Alvarez, 1,2 Francisco Aguilar, 1,2
Jose Alcon, 1,2 Empar Lurbe. 1,2 1 Hospital General
Universitario, University of Valencia, Valencia, ES;
2 Health Institute Carlos III, Madrid, ES.
Left Ventricular Geometry in Children with Primary
Hypertension: Prevalence and Predictors
Cozumel S. Pruette, 1 Barbara A. Fivush, 1 Joseph T.
Flynn, 2 Tammy M. Brady. 1 1 Johns Hopkins University,
Baltimore, MD, US; 2 Seattle Children’s Hospital,
Seattle, WA, US.
Serum Uric Acid in U.S. Adolescents: Distribution
and Relationship to Demographic Characteristics
and Cardiovascular Risk Factors
Ibrahim F. Shatat, 1 Rany T. Abdallah, 2 David J. Sas, 1
Susan M. Hailpern. 3 1 Medical University of South
Carolina Children’s Hospital, Charleston, SC, US;
2 Medical University of South Carolina, Charleston, SC,
US; 3 Independent Consultant, Katonah, NY, US.
Clinic and Ambulatory Blood Pressure
Measurements and Patterns in Asymptomatic
Children with Sickle Cell Disease
Ibrahim F. Shatat, 1 Ram V. Kalpatthi, 2 Amanda E.
Blue, 1 Katelyn Graeme, 1 Mary A. Johnson, 1 John K.
Orak, 1 Sharron M. Jackson. 1 1 Medical University of
South Carolina Children’s Hospital, Charleston, SC,
US; 2 Children’s Mercy Hospital, Kansas City, MO, US.
Risk Factors (Lipids)
PO-112:
Evaluating the Effects of Hypercholesterolemia
on Vascular Risk Profile of Treated Hypertensive
Patients. Results of a Cross-Sectional National Study
Pedro Aranda, Manuel Gorostidi, Julian Segura,
Alex de la Sierra, Jose Juan de la Cruz, Jose
Carlos Fernandez, Luis Maria Ruilope. Cardiorisk
Investigators Group, Madrid, ES.
101